Actively Recruiting
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
Led by Wake Forest University Health Sciences · Updated on 2026-04-17
115
Participants Needed
2
Research Sites
1098 weeks
Total Duration
On this page
Sponsors
W
Wake Forest University Health Sciences
Lead Sponsor
A
Atrium Health Levine Cancer Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
The overall purpose of this study is to investigate whether younger subjects report pain with pegfilgrastim (or biosimilar substitution) more often and/or at higher levels (greater intensity) than older subjects.This study will be carried out throughout the course of your chemotherapy treatment, which will be prescribed by your study doctor. Participation in this study will not affect your cancer treatment.
CONDITIONS
Official Title
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent and HIPAA authorization for release of personal health information
- Age 18 years or older at the time of consent
- Female
- Histological or cytological confirmation of invasive breast cancer
- Planned to undergo adjuvant or neoadjuvant chemotherapy treatment for invasive breast cancer AND pegfilgrastim (or biosimilar substitution) treatment for neutropenic prophylaxis
- Ability to read and understand English and/or Spanish
- Ability to understand and comply with study procedures for the entire length of the study as determined by the enrolling physician
You will not qualify if you...
- Uncontrolled illness or psychiatric/social conditions that would limit study compliance as determined by the investigator
- Previously received chemotherapy or radiation other than the first cycle of planned chemotherapy
- Taking chronic narcotics as determined by treating physician
- Diagnosis of distant metastatic breast cancer
- Diagnosis of a chronic pain syndrome (e.g. fibromyalgia, severe osteoarthritis)
- Baseline ESAS pain score greater than 8
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Levine Cancer Institute
Charlotte, North Carolina, United States, 28204
Actively Recruiting
2
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States, 27157
Actively Recruiting
Research Team
L
Laura Moore, RN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here